Examples of immune targets under investigation for the treatment of specific breast cancer subtypes include B7-H3, LAG3 and CTLA4; there is also interest in assessing the role of Bcl-2 inhibition in selected patients with breast cancer. Here, LAG3 is linked to breast cancer.